<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(21)</volume><submitter>Kovacs F</submitter><pubmed_abstract>Hybridization of steroids and other pharmacophores often modifies the bioactivity of the parent compounds, improving selectivity and side effect profile. In this study, estradiol and 3'-(un)substituted benzisoxazole moieties were combined into novel molecules by structural integration of their aromatic rings. Simple estrogen starting materials, such as estrone, estradiol and estradiol-3-methylether were used for the multistep transformations. Some of the heterocyclic derivatives were prepared from the estrane precursor by a formylation or Friedel-Crafts acylation-oximation-cyclization sequence, whereas others were obtained by a functional group interconversion strategy. The antiproliferative activities of the synthesized compounds were assessed on various human cervical, breast and prostat</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>7456</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9654004</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Substitutional Diversity-Oriented Synthesis and In Vitro Anticancer Activity of Framework-Integrated Estradiol-Benzisoxazole Chimeras.</pubmed_title><pmcid>PMC9654004</pmcid><pubmed_authors>Frank E</pubmed_authors><pubmed_authors>Nagy FI</pubmed_authors><pubmed_authors>Kiricsi M</pubmed_authors><pubmed_authors>Adamecz DI</pubmed_authors><pubmed_authors>Kovacs F</pubmed_authors><pubmed_authors>Papp B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Substitutional Diversity-Oriented Synthesis and In Vitro Anticancer Activity of Framework-Integrated Estradiol-Benzisoxazole Chimeras.</name><description>Hybridization of steroids and other pharmacophores often modifies the bioactivity of the parent compounds, improving selectivity and side effect profile. In this study, estradiol and 3'-(un)substituted benzisoxazole moieties were combined into novel molecules by structural integration of their aromatic rings. Simple estrogen starting materials, such as estrone, estradiol and estradiol-3-methylether were used for the multistep transformations. Some of the heterocyclic derivatives were prepared from the estrane precursor by a formylation or Friedel-Crafts acylation-oximation-cyclization sequence, whereas others were obtained by a functional group interconversion strategy. The antiproliferative activities of the synthesized compounds were assessed on various human cervical, breast and prostat</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T23:29:40.728Z</modification><creation>2025-04-06T09:21:46.332Z</creation></dates><accession>S-EPMC9654004</accession><cross_references><pubmed>36364293</pubmed><doi>10.3390/molecules27217456</doi></cross_references></HashMap>